Exonate is the ‘One to Watch’ in the Best Investment in Life Sciences
Exonate Limited were awarded the ‘One to Watch’ at the UK Business Angels Association Investment Awards last night.
The judges said: ‘Exonate is showing promise in developing revolutionary approaches to treatments for eye conditions, and has been backed by investors with deep industry knowledge.’
The award category celebrated investment in life sciences businesses, including pharmaceutical, biotechnologies, medical technologies and digital health. The shortlisted companies all demonstrated their capacity for innovation and successfully used angel investment and other relevant sources of finance to increase their potential to achieve high growth.
The awards were presented by Emma Sinclair MBE, a UNICEF ambassador and youngest person in the UK to have made a company public. Emma presented 14 awards, which celebrated the UK’s high-growth entrepreneurs and the investors that have backed them on their growth journey. The awards took place last night with a Gala dinner at The Dorchester Hotel, London, where over 300 leading innovators and investors joined to network and celebrate as the winners were announced.
Exonate’s CSO Professor David Bates and Chairman Sunil Shah collecting the award